CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- SC 13G Stake Amended Statement of Ownership
- FWP Offering Free Writing Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Delisting notice
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 38 of 61 · 1,218 filings